Table 2 Pathogens isolated from patients with CNS infections
Pathogens | n (%) | 2012–2015 years n (%) | 2016–2019 years n (%) |
|---|---|---|---|
Total | 86 | 39 | 47 |
Gram-positive bacteria | 51 (59.3) | 30 (76.9) | 21 (44.7) |
 Coagulase-negative Staphylococci a | 37 (43.0) | 24 (61.5) | 13 (27.7) |
 Enterococcus faecium | 5 (5.8) | 4 (10.3) | 1 (2.1) |
 Streptococcus pneumoniae | 5 (5.8) |  | 5 (10.6) |
 Staphylococcus aureus | 2 (2.3) | 2 (5.1) |  |
 Enterococcus faecalis | 1 (1.2) |  | 1 (2.1) |
 Streptococcus anginosus | 1 (1.2) |  | 1 (2.1) |
Gram-negative bacteria | 26 (30.2) | 6 (15.4) | 20 (42.6) |
 Acinetobacter baumannii | 6 (7.0) | 1 (2.6) | 5 (10.6) |
 Escherichia coli | 6 (7.0) | 3 (7.7) | 3 (6.4) |
 Klebsiella spp. b | 5 (5.8) |  | 5 (10.6) |
 Enterobacter cloacae | 2 (2.3) |  | 2 (4.3) |
 Enterobacter aerogenes | 2 (2.3) |  | 2(4.3) |
 Pseudomonas aeruginosa | 1 (1.2) |  | 1 (2.1) |
 Acinetobacter lwoffii | 1 (1.2) |  | 1 (2.1) |
 Stenotrophomonas maltophilia | 1 (1.2) | 1 (2.6) |  |
 Pseudomonas oryzihabitans | 1 (1.2) |  | 1 (2.1) |
 Brucella spp. | 1 (1.2) | 1 (2.6) |  |
Fungus | 9 (10.5) | 3 (7.7) | 6 (12.8) |
 Cryptococcus neoformans | 6 (7.0) | 2 (5.1) | 4 (8.5) |
 Aspergillus fumigatus | 1 (1.2) |  | 1 (2.1) |
 Candida parapsilosis | 1 (1.2) | 1 (2.6) |  |
 Candida tropicalis | 1 (1.2) |  | 1 (2.1) |